Rotavirus hospital surveillance in the era of immunization

Open Vaccine Journal

Volumn 3, Issue 1, 2010, Pages 89-95

  Sanzone, Aja M ^a,b   Bégué, Rodolfo E ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Epidemiology; Gastroenteritis; Genotype; Rotavirus; Rotavirus vaccine

Indexed keywords

PROTEIN VP4; PROTEIN VP7; ROTAVIRUS VACCINE; VIRUS RNA;

AMBULATORY CARE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; EMERGENCY WARD; GENETIC VARIABILITY; GENOTYPE; HOSPITAL ADMISSION; HUMAN; IMMUNIZATION; INFECTION RATE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLEX REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTION; SEQUENCE ANALYSIS; TREND STUDY; UNITED STATES; VIRUS GENE; VIRUS GENE 4; VIRUS GENE 9; VIRUS STRAIN;

EID: 79956271907     PISSN: None     EISSN: 18750354     Source Type: Journal    
DOI: 10.2174/1875035401003010089     Document Type: Article

References (21)

1. Cortese, M.; Parashar, U.D. Prevention of rotavirus gastroenteritis among infants and children. Morb. Mortal. Wkly. Rep., 2009, 58 (RR-2), 1-24.
2. Committee on Infectious Diseases. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics, 2009, 123 (5), 1412-1420.
3. Grimwood, K.; Buttery, J.P. Clinical update: rotavirus gastroenteri-tis and its prevention. Lancet, 2007, 370, 302-304.
4. Centers for Disease Control and Prevention. Delayed onset and dimished magnitude of rotavirus activity - United States, Novem-ber 2007-May 2008. Morb. Mortal. Wkly. Rep., 2008, 57 (25), 697-700.
5. Clark, H.F.; Lawley, D.; Mallette, L.A.; DiNubile, M.J.; Hodinka, R.L. Decline in cases of rotavirus gastroenteritis presenting to the Children's Hospital of Philadelphia after introduction of a pentava-lent rotavirus vaccine. Clin. Vaccine Immunol., 2009, 16 (3), 382-386.
6. th ed., Lippincott Williams and Wil-liams, Philadelphia, PA: USA 2007, pp. 1917-1958.
7. Clark, H.F.; Lawley, D.A.; Schaffer, A.; Patacsil, J.M.; Marcello, A.E.; Glass, R.I.; Jain, V.; Gentsch J. Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J. Clin. Microbiol., 2004, 42 (4), 1434-1438.
8. Freeman, M.M.; Kerin, T.; Hull, J.; Teel, E.; Esona, M.; Parashar, U.; Glass, R.I.; Gentsch, J.R. Phylogenetic analysis of novel G12 rotaviruses in the United States: a molecular search for the origin of a new strain. J. Med. Virol., 2009, 81 (4), 736-746.
9. Bégué, R.E.; Dennehy, P.H.; Huang, J.; Martin, P. Serotype variation of group A rotaviruses over nine winter epidemics in Southern New England. J. Clin. Microbiol., 1992, 30 (6), 1592-1594.
10. Gentsch, J.; Gray, J.; Iturriza, M.; Klena, J. Manual of rotavirus detection and characterization methods. WHO Department of Vaccines and Biologicals: http://www.who.int/vaccines-documents/ (accessed June 3, 2009).
11. Pavia, M.; Bianco, A.; Nobile, C.G.A.; Marinelli, P.; Angelillo, I.F. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pediatrics, 2009, 123 (6), e1103-1110.
12. Hicks, L.A.; Harrison, L.H.; Flannery, B.; Hadler, J.L.; Schaffneer, W.; Craig, A.S.; Jackson, D.; Thomas, A.; Beall, B. Lynfield, R.; Reingold, A.; Farley, M.M.; Whitney, C.G. Incidence of pneumo-coccal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis., 2007, 196 (9), 1346-1354.
13. Pichichero, M.E.; Casey, J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA, 2007, 298 (15), 1772-1778.
14. Reingold, A.; Hadler, J.; Farley, M.M.; Harrison, L.; Lynfield, R.; Lexau, C.; Bennett, N.; Thomas, A.; Craig, A.S.; Smith, P.J.; Beall, B.; Whitney, C.G.; Moore, M.; Pilishvili, T. Invasive pneumococ-cal disease in children 5 years after conjugate vaccine introduction-Eight States, 1998-2005. Morb. Mortal. Wkly. Rep., 2008, 57 (6), 144-148.
15. Gentsch, J.R.; Hull, J.J.; Teel, E.N.; Kerin, T.K.; Freeman, M.M.; Esona, M.D.; Griffin, D.D.; Bielfelt-Krall, B.P.; Banyai, K.; Jiang, B.; Cortese, M.M.; Glass, R.I.; Parashar, U.D. G and P types of cir-culating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J. Infect. Dis., 2009, 200 (Suppl 1), S99-S105.
16. Huang, J.; Wang, L.; Firth, S.; Phelps, A.; Reeves, P.; Holmes, I. Rotavirus VP7 epitope mapping using fragments of VP7 displayed on phages. Vaccine, 2000, 18 (21), 2257-2265.
17. Taniguchi, K.; Hoshino, Y.; Nishikawa, K.; Green, K.Y.; Maloy, W.L.; Morita, Y.; Urasawa, S.; Kapikian, A.Z.; Chanock, R.M.; Gorziglia, M. Cross-reactive and serotype-specific neutralizationepitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J. Virol., 1988, 62 (6), 1870-1874.
18. Green, K.Y.; Kapikian, A.Z. Identification of VP7 epitopes associ-ated with protection against human rotavirus illness or shedding in volunteers. J. Virol., 1992, 66 (1), 548-553.
19. Franco, M.A.; Prieto, I.; Labbé, M.; Poncet, D.; Borras-Cuesta, F.; Cohen J. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J. Gen. Virol., 1993, 74 (12), 2579-2586.
20. Hansen, G.; Mehnert, F.; Streckert, H.J.; Werchau, H. Monoclonal antipeptide antibodies recognize epitopes upon and VP7 of simian rotavirus SA11 in infected MA104 cells. Arch. Virol., 1992, 122 (3-4), 281-291.
21. Zhou, Y.J.; Burns, J.W.; Morita, Y.; Tanaka, T.; Estes, M.K. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J. Virol., 1994, 68 (6), 3955-3964.